Key Takeaways:
A securities class action lawsuit has been filed against Lufax Holding Ltd. (NYSE: LU), targeting nearly two years of alleged false statements and internal control failures that investors claim led to financial damages.
Multiple law firms, including Rosen Law Firm and Bronstein, Gewirtz & Grossman, announced the lawsuit on behalf of purchasers of Lufax securities between April 7, 2023, and January 26, 2025. "If you purchased Lufax securities during the Class Period you may be entitled to compensation," a statement from Rosen Law Firm noted. The deadline for investors to move the Court to serve as lead plaintiff is May 20, 2026.
The lawsuit alleges that Lufax made materially false and misleading statements and failed to disclose significant weaknesses in its operations. The core allegations state that the company: (1) lacked adequate internal controls; (2) certain of its financial results were materially misstated; and (3) its statements about business, operations, and prospects were consequently misleading.
The action follows a period of scrutiny for the financial technology company, with the lawsuit claiming that investors suffered damages when the alleged true details about the company's health entered the market. The case seeks to recover these damages for the affected class of investors.
This lawsuit places Lufax under significant legal and financial pressure, potentially impacting its stock valuation as the litigation proceeds. Investors will be watching for the company's formal response to the allegations and any subsequent filings before the May 2026 lead plaintiff deadline.
This article is for informational purposes only and does not constitute investment advice.
